Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer’s Disease Treated with Rivastigmine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 35, Iss. 1-2, 2013-01 ,pp. : 23-33

Karger

Access to resources Recommend Favorite

Factors Associated with Caregivers’ Underestimation of Quality of Life in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 33, Iss. 1, 2012-02 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Response to Rivastigmine Transdermal Patch or Memantine plus Rivastigmine Patch is affected by Apolipoprotein E Genotype in Alzheimer Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 34, Iss. 3-4, 2012-10 ,pp. : 167-173

Karger

Access to resources Recommend Favorite

Effects of Rivastigmine Transdermal Patch and Capsule on Aspects of Clinical Global Impression of Change in Alzheimer’s Disease: A Retrospective Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 29, Iss. 5, 2010-05 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

Does Rivastigmine Improve Cognitive Functions or Disability in Patients with Alzheimer’s Disease?

By  

Neuroepidemiology, Vol. 23, Iss. 4, 2004-07 ,pp. : 209-210

Karger

Access to resources Recommend Favorite